S
REPL icon

SignatureFD’s Replimune Group REPL Stock Holding History

SignatureFD’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.1K Buy
2,361
+175
+8% +$1.34K ﹤0.01% 2244
2025
Q4 		$21.2K Buy
2,186
+906
+71% +$7.7K ﹤0.01% 2096
2025
Q3 		$5.36K Sell
1,280
-3,542
-73% -$22.6K ﹤0.01% 2639
2025
Q2 		$44.8K Buy
4,822
+393
+9% +$3.43K ﹤0.01% 1637
2025
Q1 		$43.2K Buy
4,429
+164
+4% +$2.03K ﹤0.01% 1662
2024
Q4 		$51.6K Sell
4,265
-172
-4% -$2.09K ﹤0.01% 1572
2024
Q3 		$48.6K Buy
4,437
+750
+20% +$7.62K ﹤0.01% 1591
2024
Q2 		$33.2K Sell
3,687
-1,668
-31% -$11.6K ﹤0.01% 1721
2024
Q1 		$43.8K Buy
5,355
+3,936
+277% +$32.3K ﹤0.01% 1620
2023
Q4 		$12K Buy
1,419
+1,379
+3,448% +$16K ﹤0.01% 2178
2023
Q3 		$684 Sell
40
-26
-39% -$511 ﹤0.01% 2986
2023
Q2 		$1.53K Buy
66
+26
+65% +$508 ﹤0.01% 2876
2023
Q1 		$706 Sell
40
-9
-18% -$214 ﹤0.01% 3051
2022
Q4 		$1.33K Buy
49
+9
+23% +$187 ﹤0.01% 2911
2022
Q3 		$1K Hold
40
– – ﹤0.01% 3017
2022
Q2 		$1K Hold
40
– – ﹤0.01% 2995
2022
Q1 		$1K Buy
+40
New +$755 ﹤0.01% 3047

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SignatureFD's REPL Position: Q1 2026 in Review

SignatureFD increased its Replimune Group (REPL) stake by 8% in Q1 2026, buying an estimated $1.34K and bringing the position to 2,361 shares worth $18.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2244.

SignatureFD first reported a position in REPL in Q1 2022 and has held it in 17 quarters since. The position peaked at $51.6K in Q4 2024. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • SignatureFD held 2,361 shares of Replimune Group worth $18.1K as of Q1 2026.
  • SignatureFD bought 175 Replimune Group shares in Q1 2026, an estimated $1.34K.
  • Replimune Group made up ﹤0.01% of SignatureFD's portfolio in Q1 2026, its #2244 holding.
  • SignatureFD first reported a position in Replimune Group in Q1 2022 and has held it in 17 quarters since.
  • SignatureFD's Replimune Group position peaked at $51.6K in Q4 2024.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.